Medical device company St. Jude Medical has completed its acquisition of privately held CardioMEMS, developer of the CardioMEMS HF System.
“St. Jude Medical’s acquisition of CardioMEMS shows our commitment to providing innovative medical device solutions that reduce the burden of complex diseases like heart failure, both on patients and health care systems,” said St. Jude Medical Chairman, President and CEO Daniel J. Starks. “The CardioMEMS HF System achieves this goal by setting a new treatment paradigm for heart failure that reduces hospitalizations and improves the quality of life for patients.”
The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device proven to significantly reduce hospital admissions when used by physicians to manage heart failure. St. Jude Medical will now begin its strategic launch of the CardioMEMS HF System in the U.S.